Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study
Kee-Ho Song (Song KH), Jung Min Kim (Kim JM), Jung-Hyun Noh (Noh JH), Yongsoo Park (Park Y), Hyun-Shik Son (Son HS), Kyong Wan Min (Min KW), Kyung Soo Ko (Ko KS)
Diabetes Metab J. 2013;37(2):117-124.   Published online 2013 Apr 16     DOI: https://doi.org/10.4093/dmj.2013.37.2.117
Citations to this article as recorded by Crossref logo
15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes
Andreas Liebl, Viswanathan Mohan, Wenying Yang, Krzysztof Strojek, Sultan Linjawi
Drugs in R&D.2018; 18(1): 27.     CrossRef
Basal-prandial versus premixed insulin in patients with type 2 diabetes requiring insulin intensification after basal insulin optimization: A 24-week randomized non-inferiority trial
Sang-Man Jin, Jae Hyeon Kim, Kyung Wan Min, Ji Hyun Lee, Kue Jeong Ahn, Jeong Hyun Park, Hak Chul Jang, Seok Won Park, Kwan Woo Lee, Kyu Chang Won, Young-Il Kim, Choon Hee Chung, Tae Sun Park, Jee-Hyun Lee, Moon-Kyu Lee
Journal of Diabetes.2016; 8(3): 405.     CrossRef
The optimal morning:evening ratio in total dose of twice-daily biphasic insulin analogue in poorly controlled Type 2 diabetes: a 24-week multi-centre prospective, randomized controlled, open-labelled clinical study
C. H. Jung, J.-Y. Park, J. H. Cho, K.-H. Yoon, H. K. Yang, Y.-H. Lee, B. S. Cha, B.-W. Lee
Diabetic Medicine.2014; 31(1): 68.     CrossRef
Response: Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study (Diabetes Metab J2013;37:117-24)
Kee-Ho Song, Jung Min Kim, Jung-Hyun Noh, Yongsoo Park, Hyun-Shik Son, Kyong Wan Min, Kyung Soo Ko
Diabetes & Metabolism Journal.2013; 37(3): 214.     CrossRef
Letter: Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study (Diabetes Metab J2013;37:117-24)
Byung-Wan Lee
Diabetes & Metabolism Journal.2013; 37(3): 212.     CrossRef